
Inovio Pharmaceuticals Inc
NASDAQ:INO

Intrinsic Value
The intrinsic value of one
INO
stock under the Base Case scenario is
20.59
USD.
Compared to the current market price of 2.12 USD,
Inovio Pharmaceuticals Inc
is
Undervalued by 90%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Inovio Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Inovio Pharmaceuticals Inc
Balance Sheet Decomposition
Inovio Pharmaceuticals Inc
Current Assets | 71.9m |
Cash & Short-Term Investments | 68.4m |
Receivables | 1.3m |
Other Current Assets | 2.2m |
Non-Current Assets | 15.4m |
Long-Term Investments | 2.3m |
PP&E | 11.1m |
Other Non-Current Assets | 2m |
Free Cash Flow Analysis
Inovio Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Inovio Pharmaceuticals Inc
Revenue
|
283.1k
USD
|
Operating Expenses
|
-106.2m
USD
|
Operating Income
|
-106m
USD
|
Other Expenses
|
9.5m
USD
|
Net Income
|
-96.5m
USD
|
INO Profitability Score
Profitability Due Diligence
Inovio Pharmaceuticals Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Score
Inovio Pharmaceuticals Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.
INO Solvency Score
Solvency Due Diligence
Inovio Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Score
Inovio Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INO Price Targets Summary
Inovio Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
INO
is 8.16 USD
with a low forecast of 2.02 USD and a high forecast of 13.65 USD.
Dividends
Current shareholder yield for INO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
INO
stock under the Base Case scenario is
20.59
USD.
Compared to the current market price of 2.12 USD,
Inovio Pharmaceuticals Inc
is
Undervalued by 90%.